Abstract
Obtaining utility values for disease modelling in rare conditions is challenging. Late-onset Pompe disease (LOPD), an inherited metabolic disorder, is characterised by progressive muscle weakness leading to increasing disability and patient dependence on wheelchair and ventilator use. There is scarce evidence on the utility associated with disability, however, SF-36 is frequently measured in clinical practice. This research aims to investigate the impact of need for wheelchair and ventilator use on utility in patients with LOPD using SF-36 data from the Pompe Registry (NTC00231400/Sanofi Genzyme).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.